Praxis Precision Medicines Inc.
Organization details
- Legal name
- Praxis Precision Medicines Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PRAX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001689548
Board of directors
-
Dean J. Mitchell · DirectorSince 2023
-
Gregory Norden · DirectorSince 2023
-
Jeffrey B. Kindler · DirectorSince 2026
-
Jeffrey Chodakewitz · DirectorSince 2023
-
Jill DeSimone · DirectorSince 2023
-
Marcio Souza · Director · Chief Executive OfficerSince 2023
-
Merit Ester Cudkowicz · DirectorSince 2023
-
Stuart A. Arbuckle · DirectorSince 2026
-
William D. Young · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.5%
-
98.8%
-
99.5%
Board connections
6 of this board's directors also sit on 9 other boards. 9 are in the same sector.
-
Precigen Inc. Same sectorvia Dean J. Mitchell and Jeffrey B. Kindler
-
Adicet Bio Inc. Same sectorvia Jeffrey Chodakewitz
-
Alnylam Pharmaceuticals Inc. Same sectorvia Stuart A. Arbuckle
- via William D. Young
-
Perrigo Company plc Same sectorvia Jeffrey B. Kindler
-
Rhythm Pharmaceuticals Inc. Same sectorvia Stuart A. Arbuckle
-
Royalty Pharma plc Same sectorvia Gregory Norden
-
Schrodinger Inc. Same sectorvia Jeffrey Chodakewitz
-
Zoetis Inc. Same sectorvia Gregory Norden
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $11,075,794
- 18 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Marcio Souza Director, Officer (Chief Executive Officer) | Gift | −20,521 | — | — |
| Jul 8, 2026 | Marcio Souza Director, Officer (Chief Executive Officer) | Gift | −2,600 | — | — |
| Jun 24, 2026 | Jill DeSimone Director | Option exercise | +8,566 | $44.25 | $379,046 |
| Jun 24, 2026 | Jill DeSimone Director | Option exercise | +3,034 | $147.30 | $446,908 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −10 | $301.44 | $3,014 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −120 | $303.13 | $36,376 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −320 | $305.31 | $97,699 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −683 | $306.77 | $209,524 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −1,240 | $308.24 | $382,218 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −999 | $309.38 | $309,071 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −1,750 | $310.89 | $544,058 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −2,854 | $311.91 | $890,191 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −1,004 | $312.83 | $314,081 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −504 | $313.66 | $158,085 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −1,279 | $314.90 | $402,757 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Praxis Precision Medicines Inc.
Who is the CEO of Praxis Precision Medicines Inc.?
Marcio Souza is Praxis Precision Medicines Inc.'s Chief Executive Officer.
How many directors are on Praxis Precision Medicines Inc.'s board?
Praxis Precision Medicines Inc.'s board has 9 directors: Dean J. Mitchell, Gregory Norden, Jeffrey B. Kindler, Jeffrey Chodakewitz, Jill DeSimone, Marcio Souza, Merit Ester Cudkowicz, Stuart A. Arbuckle and William D. Young.
Are Praxis Precision Medicines Inc. insiders buying or selling shares?
Over the last 12 months, Praxis Precision Medicines Inc. insiders made no open-market purchases and sold $11.1 million of shares in 18 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="praxis-precision-medicines-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.